Olympus

The University of Houston has been awarded

Peter Rogan has been awarded US Patent No. 8,532,934, "Rapid and comprehensive identification of prokaryotic organisms by metagenomic analysis."

Enzo Diagnostics has been awarded US Patent No. 8,445,664, "Kits for amplifying and detecting nucleic acid sequences."
Elazar Rabbani, Jannis Stavrianopoulos, James Donegan, Jack Coleman, and Marleen Walter are named as inventors.

Universidad Politecnica de Valencia of Valencia, Spain, has received US Patent No.

Downloads and Upgrades

Premium

CellSens Dimension Database Solution

Life Technologies, Siemens, NuGen Technologies, Olympus, Riken, Hologic, and Qiagen win US patents.

Beckman Coulter completed the $780 million deal over this past weekend.

Beckman said the closing payment for the deal would fixed at $780 million. It also said that it would eliminate Olympus' immunoassay product line and related R&D efforts after the closing of the deal.

The $800 million acquisition will strengthen Beckman Coulter's presence in the clinical chemistry market. The firm does not anticipate a change in its current investment grade ratings due to the new debt.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.